Rep. Donald G. Davis

Maddy summaryHR 9814, the Rural Homeownership Continuity Act of 2024, simplifies the process for rural homeowners to transfer FHA-guaranteed mortgages when selling their homes. It requires the Secretary of Housing and Urban Development to create a rule within one year establishing a process allowing a qualified buyer to assume the existing loan, while fully relieving the original borrower and any co-borrowers or guarantors of liability. This directly affects rural homeowners using the Doug Bereuter Section 502 Single Family Housing Loan Guarantee Program who wish to sell their property without remaining responsible for the mortgage. The key provision eliminates the seller's ongoing financial obligation upon a successful transfer to a qualified buyer.

Maddy summaryHR 8119, the PEARL Act, establishes a 3-year pilot program at U.S. Customs and Border Protection (CBP) to adopt therapy dogs from local animal shelters for emotional support of CBP personnel. The bill requires the Secretary of Homeland Security to create the program within 60 days of enactment, train shelter dogs as therapy dogs, and reimburse CBP for related costs. It also authorizes $1,000,000 for CBP's existing Support Canine Program. The bill directly affects CBP officers and staff by introducing a new emotional wellness resource through therapy dog interactions.

Maddy summaryHR 1719, the Honoring Our Fallen Heroes Act of 2023, establishes a presumption that certain cancers diagnosed in public safety officers (like police and firefighters) are work-related if linked to their duties. It defines 22 specific cancers (including lung, mesothelioma, and WTC-related cancers) as "exposure-related," allowing officers or their families to receive benefits without proving direct work connection, provided they were diagnosed within 15 years of leaving active service. The bill also creates a process for adding new cancers to the list based on scientific evidence, requiring the Bureau to review petitions and make decisions within 180 days. This applies to deaths or disabilities occurring on or after January 1, 2023, directly affecting officers who developed covered cancers during service.

Maddy summaryThe CLAWS Act of 2024 requires U.S. federal agencies (like NIH or the Department of Defense) to annually report detailed information about biomedical research projects funded by U.S. agencies but conducted in China or involving Chinese entities. The report must include specifics such as the project's purpose, whether it involves pandemic-potential pathogens or military-linked research locations, funding details, security measures, and any compliance issues. This applies to all federally funded biomedical research - such as disease treatment or vaccine development - carried out in China or with Chinese partners. The goal is to increase transparency about research collaborations with China, focusing on security and oversight.

Maddy summaryHR 9782, the Uterine Cancer Study Act of 2024, directs the U.S. Department of Health and Human Services (HHS) to study whether hair straighteners - specifically chemical products - may be linked to uterine cancer, with a focus on higher rates among women of color. The study will review existing research, examine impacts across racial and ethnic groups, and break down results by product type (e.g., dyed, bleached, or permed straighteners). HHS must submit a study methodology within 45 days of the bill’s enactment and complete the study, reporting findings to Congress within two years. The bill does not impose new regulations but may inform future FDA safety requirements for hair straightening products. This affects women of color disproportionately impacted by uterine cancer and the broader population using such products.

Maddy summaryThe DISPOSE Act authorizes the U.S. government to partner with Colombia, Mexico, and Peru to safely destroy chemicals used in illegal drug production. It requires the State Department, in coordination with Justice and Defense, to create a detailed implementation plan within 90 days - including timelines, budgets, and measurable goals - and provide annual progress reports to Congress on chemical destruction efforts. The initiative aims to prevent these chemicals from re-entering drug manufacturing, free storage space for future seizures, and reduce environmental harm from hazardous waste.

Maddy summaryThis bill clarifies Medicare rules to allow doctors to provide certain critical medications directly in their offices without extra administrative hurdles. It specifically amends a Medicare provision (Section 1877(b)(2) of the Social Security Act) to remove a requirement that drugs furnished in-office must follow specific administrative rules, effective May 11, 2023. The bill also directs the removal of conflicting Medicare guidance published in 2021 and 2023, which had previously restricted this practice. This change directly affects Medicare beneficiaries (seniors) and doctors' offices that supply covered medications during patient visits. It streamlines access to necessary drugs by eliminating an unnecessary barrier to in-office medication administration under Medicare.

Maddy summaryHR 3433, the "Give Kids a Chance Act of 2024," requires pharmaceutical companies developing certain cancer drugs to conduct pediatric studies if the drugs target molecular pathways relevant to childhood cancers. It directly affects drug manufacturers submitting new applications for cancer treatments, particularly those combining previously approved adult cancer drugs or containing a single new active ingredient. The bill amends FDA regulations to mandate these pediatric investigations only when specific conditions are met, such as when a drug's molecular target is relevant to pediatric cancer growth. The FDA must issue implementing guidance within 12 months, and reports to Congress will track implementation and effectiveness starting 2 years after enactment.

Maddy summaryThis bill prohibits hospitals and transplant centers from denying organ transplants or related services to people with disabilities solely because of their disability. It requires covered entities to make reasonable modifications to policies (like considering a patient's support network for post-transplant care) and provide auxiliary aids (such as communication services or accessible health information). The law specifically prevents discrimination based on disability during evaluation, listing, and treatment, while clarifying that medical decisions must be based on individualized assessments - not disability alone. It applies to all organ transplant processes and allows individuals to file complaints with the Department of Health and Human Services or sue for violations.

Maddy summaryHCONRES 129 designates the week of September 22-28, 2024, as "National Fall Prevention Awareness Week" to raise public awareness about falls among older adults. The resolution cites CDC data showing falls cause approximately 14 million incidents, 3 million emergency visits, and $80 billion in annual medical costs for adults aged 65+. It supports existing evidence-based prevention strategies - such as balance exercises, home safety modifications, and medication management - without creating new legal requirements or funding. The bill focuses on awareness and collaboration among government agencies, healthcare providers, and community organizations to reduce fall risks.